COTY · COTY INC · Stock research

Current Thesis

The leg on offer here has never been a demand recovery; it is balance-sheet repair at a levered fragrance-and-mass-beauty operator. The 2026-08-19 Q4 FY26 print finally attached numbers to it, and the numbers neither funded nor killed the story. Financial net debt closed FY26 at $2,912.1M against $3,088.2M of total debt, down from $3.75B at the end of FY25 with help from the $750M Wella divestiture cash taken in December 2025 — yet reported leverage still came in at 3.4x, because FY26 adjusted EBITDA fell 22% to $846.9M. The denominator ate the repair. Management then withheld full-year FY27 guidance, deferring the outlook until the Consumer Beauty strategic review completes "by the end of CY26." RBC Capital cut the stock to Sector Perform from Outperform on 2026-08-20 and took its target to $3 from $8. Against the 2026-08-21 close of $2.74, an 18-analyst S&P Global consensus sits at Hold with an average target of $3.17 — down from the $3.70 average that stood on 2026-08-12. The binary passed; what it produced was a deferral to a review deadline four months out.

Bullish and bearish views on COTY INC

The model's bull view on COTY INC (COTY), in brief: The FY26 EBITDA guide held. FY26 adjusted EBITDA of $846.9M landed inside the guided $838–848M band, and Q4 adjusted EBITDA of $93.6M landed inside the guided $85–95M range — near its top — despite Q4 like-for-like revenue at -1% (release, 2026-08-19). the miss was on the bottom… The bear view: Leverage did not move. Net debt fell roughly $840M across FY26, and the leverage multiple still printed 3.4x on 2026-06-30 — the same ~3.3–3.4x the de-lever narrative started from. Paying down debt into a 22% EBITDA decline is running to stand still. No FY27 full-year guide… Both cases follow in full.

Bull Case

• The FY26 EBITDA guide held. FY26 adjusted EBITDA of $846.9M landed inside the guided $838–848M band, and Q4 adjusted EBITDA of $93.6M landed inside the guided $85–95M range — near its top — despite Q4 like-for-like revenue at -1% (release, 2026-08-19).
• the miss was on the bottom line, at -$0.02 adjusted EPS versus -$0.01 expected.
• Cash generation improved while sales fell. FY26 free cash flow of $348.2M was +25% versus $277.6M the prior year, on $537.8M of operating cash flow; Q4 free cash flow was $72.6M against $34.9M a year earlier. Management guided H1 FY27 free cash flow above $300M (release, 2026-08-19).
• Two disposals still sit outside the current numbers. The Gucci beauty licence returns to Kering roughly a year early for $400M plus inventory proceeds, with Coty operating the brand through at least 2027-06-30; the CoverGirl / Rimmel / Sally Hansen / Max Factor review opened 2025-09-29 covers a $1.2B revenue block plus a Brazil business near $400M, with Citi advising.
• A fixed-cost programme is attached to the Gucci exit. The 2026-08-19 release flags a "significant fixed cost reduction program" in connection with the licence handover — the offset management is pointing at for the FY28 step-down it acknowledged the same day.

Bear Case

• Leverage did not move. Net debt fell roughly $840M across FY26, and the leverage multiple still printed 3.4x on 2026-06-30 — the same ~3.3–3.4x the de-lever narrative started from. Paying down debt into a 22% EBITDA decline is running to stand still.
• No FY27 full-year guide exists. The company gave only Q1: like-for-like revenue down low-to-mid single digits, adjusted gross margin down 50–100bps, adjusted EBITDA down a low-teens percentage, adjusted EPS $0.11–$0.13 against a $0.14 consensus. Anyone underwriting FY27 earnings is doing it without a company number until the review closes.
• The most constructive covering analyst capitulated. RBC's 2026-08-20 move from Outperform/$8 to Sector Perform/$3 removes the top end of the target distribution; the S&P Global average target of $3.17 leaves a narrow gap to the 2026-08-21 close of $2.74.
• Margin erosion is continuous, not one-off. FY26 gross margin of 62.9% was -190bps; Q4 gross margin of 60.9% was -140bps; Q3 FY26 adjusted gross margin was 61.8%, -250bps YoY. Three consecutive quarters of the same direction.
• Revenue leaves by contract as well as by demand. Management stated on 2026-08-19 that the Gucci exit produces a step-down in sales and profit in FY28. Burberry fragrance remains licensed. Kering Beauté's in-house build is a template other brand owners can copy.
• Leadership is unsettled at both seats. Markus Strobel has been Executive Chairman and interim CEO since the 2026-07-02 reorganisation; Soraya Benchikh becomes CFO on 2026-09-01, succeeding Laurent Mercier. A permanent CEO arriving with a rebased plan is a common route to a lower guide.

Setup & Price Structure

The narrative is maturing. The story is well known, the structure it built in July is still intact, and the flow behind it is moderating rather than expanding. What dates the call is the 2026-08-19/20 sequence: the print landed mixed, the stock slipped on the session and traded lower again pre-market 2026-08-20, and the one clearly bullish rating on the tape was withdrawn that morning. Fresh-headline supply is now thin until the review concludes.

Measured levels. The 2026-08-21 close of $2.74 is above the 50-day moving average of $2.32 and the 200-day of $2.37 as measured on 2026-08-12 (MarketBeat) — the reclaim of both, the first this year, has survived the print. The shares are up 35.0% over three months and sit 38.4% below the $4.45 52-week high. RSI(14) at 48.3 on 2026-08-21 has cooled from 57.3 on 2026-08-14, so the post-print fade unwound the momentum extension without breaking the base. The 2026-06-29 all-time low of $1.82 is the floor the June reversal was drawn from.

Crowding and positioning observables, stated as observables. Price sits materially above a rising 50-day, which is the standard shape of a name that has run before its fundamentals confirmed. Coverage is not crowded on the bull side: 18 analysts, consensus Hold, average target $3.17 against a $2.74 close, and one downgrade dated 2026-08-20. Institutional ownership was 42.36% on 2026-08-12. Short interest is mid-single-digit as a share of float, so squeeze mechanics are not part of this setup despite the sub-$3 quote. There is no earnings date inside 30 days — the next scheduled print is Q1 FY27, historically early November. Liquidity metrics on 2026-08-12 were a current ratio of 0.82 and a quick ratio of 0.49, with debt-to-equity 0.97.

Catalyst Calendar (next 30 days)

• 2026-09-01 — Soraya Benchikh takes over as CFO from Laurent Mercier (announced 2026-08-19). The first observable is whether the new CFO restates or re-frames the leverage path management declined to guide on 2026-08-19.
• Between 2026-08-24 and 2026-09-22 (undated) — any announcement on the Consumer Beauty strategic review opened 2025-09-29. Management committed only to completion "by the end of CY26," so a named buyer or structure inside the window would arrive ahead of schedule and would be the single largest change to the leverage arithmetic.
• ~2026-09-15 (est.) — FY26 Form 10-K filing, following the 2026-08-19 results release. The covenant, maturity-schedule and going-forward liquidity language is the check on whether 3.4x leverage carries any documented constraint.
• ~2026-11-05 (est.), outside the window — Q1 FY27 results, the first test of the $0.11–$0.13 adjusted EPS guide and of low-to-mid single-digit like-for-like decline.

What Would Change Our Mind

The structure that has to hold is the July reclaim of the 50-day and 200-day moving averages, measured at $2.32 and $2.37 on 2026-08-12. Losing it — a daily close below $2.35 — returns the tape to the downtrend it broke in June and puts the 2026-06-29 all-time low of $1.82 back in play; a weekly close under $1.82 would confirm that retest.

On fundamentals, three separate outcomes would break the leg independent of price. First, the Consumer Beauty review reaching its end-CY26 deadline with no transaction announced: that removes the largest remaining de-levering lever and leaves the story dependent on organic cash flow against a 22%-declining EBITDA base. Second, an FY27 outlook issued below the FY26 adjusted EBITDA of $846.9M by enough to push reported leverage above 3.4x on the next disclosure — the mechanism that neutralised $840M of debt reduction in FY26. Third, any announcement affecting the Burberry fragrance licence or another top prestige licence, which would extend the Gucci precedent from a one-off to a pattern of contractual revenue loss.

What would strengthen the case instead: a signed Consumer Beauty transaction with proceeds and timing attached, or a Q1 FY27 print that comes in above the $0.11–$0.13 adjusted EPS guide with like-for-like revenue better than the low-to-mid single-digit decline guided.

Correlation Notes

• Kering is the counterparty, not a comp. The $400M Gucci licence handover means Coty's prestige revenue base is set partly by another company's in-house ambitions. Kering Beauté decisions read across to Coty's remaining licensed portfolio more directly than beauty demand data does.
• Divergence from the beauty complex on the print date. On 2026-08-19 Estée Lauder was listed among large caps moving higher while Coty slipped on its own results — the name is trading on its own balance sheet and disposal timeline more than on sector beta. Reported beta was 0.97 on 2026-08-12 (MarketBeat).
• Credit sensitivity. At 3.4x net leverage with $3,088.2M of total debt on 2026-06-30, the equity is a residual claim whose value moves with refinancing conditions as much as with revenue. High-yield spread widening is a transmission channel that has nothing to do with lipstick volumes.
• Travel retail and the Middle East. Q3 FY26 like-for-like sales of -7% were attributed to disruption in those channels (2026-05-06 results). Duty-free operators and peers with Asian travel-retail exposure reporting weakness are the read-across to watch ahead of the Q1 FY27 print.
• Currency. Reported FY26 revenue fell 2% while like-for-like fell 5%, so translation was working in the reported line's favour across FY26; a dollar reversal moves the reported number without changing the operating trend.